NIH-funded research R01 grant

Investigating biomarkers for diagnosing alcoholic acute pancreatitis

Official title: Biomarkers and pathogenesis of Alcoholic acute pancreatitis

Funded at Mayo Clinic Arizona · NIH-11045636 · Data updated 2026-11-12

This study is looking to find a better way to diagnose alcoholic acute pancreatitis by checking for specific fatty acids in the blood, which could help doctors tell how serious the condition is, even when other tests don’t work well.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Arizona
NIH-funded
Lab location1 site (Scottsdale, United States)
Project startMarch 1, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$517,938
NIH project number5R01AA031257-02
Project IDNIH-11045636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been diagnosed with acute pancreatitis, particularly those with a history of alcohol consumption.

Less likely to help

Patients who do not have acute pancreatitis or those whose condition is unrelated to alcohol consumption may not benefit from this research.

What this research studies

This research focuses on improving the diagnosis of alcoholic acute pancreatitis (AAP), a condition that affects many patients but is often misdiagnosed due to unreliable biomarkers. The study aims to validate fatty acids ethyl esters (FAEEs) as potential biomarkers that can indicate the presence and severity of AAP, even in cases where traditional alcohol detection fails. By analyzing blood samples for FAEEs, researchers hope to provide a more accurate diagnosis and better predict patient outcomes. The study will involve comparing FAEE levels in patients with AAP against those with other forms of acute pancreatitis.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment strategies for patients suffering from alcoholic acute pancreatitis.

How similar studies have gone: Previous research has shown promise in using biomarkers like FAEEs for diagnosing other alcohol-related conditions, suggesting potential success for this approach in AAP.

Where this research is happening

  • Mayo Clinic Arizona
    Scottsdale, United States
    Active

Researchers

  • Principal investigator: Singh, Vijay Prem — Mayo Clinic Arizona
  • Study coordinator: Singh, Vijay Prem

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.